Analyzing COVID-19 vaccine efficacy in vulnerable communities: efforts beyond addressing vaccine inequity
Clin Microbiol Infect
.
2022 Aug;28(8):1053-1054.
doi: 10.1016/j.cmi.2022.04.012.
Epub 2022 May 6.
Authors
Parham Sendi
1
,
Aaron J Tande
2
Affiliations
1
Institute for Infectious Diseases, University of Bern, Bern, Switzerland. Electronic address: parham.sendi@ifik.unibe.ch.
2
Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, MN, USA.
PMID:
35526690
PMCID:
PMC9072754
DOI:
10.1016/j.cmi.2022.04.012
No abstract available
Publication types
Editorial
Comment
MeSH terms
COVID-19 Vaccines
COVID-19* / prevention & control
Health Services Accessibility
Humans
Vaccination
Vaccine Efficacy
Vaccines*
Substances
COVID-19 Vaccines
Vaccines